BONE MARKERS IN THE REGULATION OF OSTEOPOROSIS ASSOCIATED WITH PREGNANCY AND LACTATION

Аббосхужаева Лола Сайдиганижоджаевна, Акрамова Гулзода Гайратуллаевна, Шакирова Мунаввара Мухитдиновна, Исамухамедова Истиора Санджаровна, Алиханова Нодира Миршовкатовна, Тахирова Феруза Абраровна

Марказий Осиё эндокринологик журнали · 2024-yil

Annotatsiya

Objective: Changes in bone density and bone markers suggest that pregnancy is associated with poorer maternal bone mass. Calcium metabolism is restored to meet the needs associated with the construction of the fetal skeleton. The fetus contributes to this process by removing regulators from the placenta. Understanding of the entire process is limited, but some changes are clear. Aim: To study the influence of risk factors such as the OPG/RANKL ratio in the development of osteoporosis associated with pregnancy and lactation. Materials and methods: To fulfill the objectives of the study, we formed 2 groups of subjects. The first, main group consisted of 27 women who developed back pain during pregnancy and/or lactation and an MRI study revealed compression fractures of the vertebrae of various locations. The second, control group consisted of 14 women without fractures and complaints of back pain in the anamnesis. Results: A comparative analysis in the main and control groups showed that, depending on the activity of β-cross laps, the average OPG value in the main group of women with normal and increased bone tissue resorption was comparable. At the same time, the average RANKL values ​​in the main group, in the subgroup with normal resorption, are significantly lower than in the group with increased resorption (1,74±0,51 and 0,78±0,18). The average RANKL values ​​in the control group and in the subgroup with normal resorption are also lower than in the group with increased resorption (80,13±21,4 and 232,4±87,8).  A comparative analysis of the OPG/RANKL ratio in the main group, in the subgroup with normal resorption was higher than in the subgroup with increased resorption and amounted to 0,025;0,0010 respectively. At the same time, in the control group there were no differences in subgroups. The OPG/RANKL ratio in women of the main and control groups with normal resorption was higher, and in the group with increased resorption this ratio was higher (0,025 and 0,01; 0,007 and 0,001). Conclusion: Various methods of osteoclastic differentiation treatment are used as the main treatment method, such as induction of osteoclastic differentiation, research and modeling of osteoclastic differentiation. The main group of osteoprotegerin (OPG) contained 0.78 pg/ml, the control group 1.74 pg/ml (P=0.005) eddy. In the main group, the RANKL is 232.4 pg/ml, in the control group 80.13 =49.3 pg/ml (P=0.05) eddy. The main group of Ranklga osteoprotegerining, compared with the control group, has a low edi index close to a trillion (P = 0.01).

Maqola ma’lumotlari
MualliflarАббосхужаева Лола Сайдиганижоджаевна, Акрамова Гулзода Гайратуллаевна, Шакирова Мунаввара Мухитдиновна, Исамухамедова Истиора Санджаровна, Алиханова Нодира Миршовкатовна, Тахирова Феруза Абраровна
JurnalМарказий Осиё эндокринологик журнали
Nashr sanasi2024-11-06
Jild4
Son2
TilO‘zbek

Kalit so‘zlar

остеопороз связанный с беременностью и лактацией, RANKL, OPG, β-cross laps, osteoporosis associated with pregnancy and lactation, RANKL, OPG, β-cross laps, ҳомиладорлик ва лактация билан боғлиқ остеопороз, RANKL, OPG, β-kross laps

Ilmiy soha

Марказий Осиё эндокринологик журнали jurnalidan boshqa maqolalar

Марказий Осиё эндокринологик журнали — barcha maqolalar